CD8+CD161+ T-Cells: Cytotoxic Memory Cells With High Therapeutic Potential
- PMID: 33597948
- PMCID: PMC7882609
- DOI: 10.3389/fimmu.2020.613204
CD8+CD161+ T-Cells: Cytotoxic Memory Cells With High Therapeutic Potential
Abstract
NK1.1 and its human homolog CD161 are expressed on NK cells, subsets of CD4+ and CD8+ T cells, and NKT cells. While the expression of NK1.1 is thought to be inhibitory to NK cell function, it is reported to play both costimulatory and coinhibitory roles in T-cells. CD161 has been extensively studied and characterized on subsets of T-cells that are MR1-restricted, IL-17 producing CD4+ (TH17 MAIT cells) and CD8+ T cells (Tc17 cells). Non-MAIT, MR1-independent CD161-expressing T-cells also exist and are characterized as generally effector memory cells with a stem cell like phenotype. Gene expression analysis of this enigmatic subset indicates a significant enhancement in the expression of cytotoxic granzyme molecules and innate like stress receptors in CD8+NK1.1+/CD8+CD161+ cells in comparison to CD8+ cells that do not express NK1.1 or CD161. First identified and studied in the context of viral infection, the role of CD8+CD161+ T-cells, especially in the context of tumor immunology, is still poorly understood. In this review, the functional characteristics of the CD161-expressing CD8+ T cell subset with respect to gene expression profile, cytotoxicity, and tissue homing properties are discussed, and application of this subset to immune responses against infectious disease and cancer is considered.
Keywords: CD161; KLRB1; T-cell; TH1 polarization; effector memory.
Copyright © 2021 Konduri, Oyewole-Said, Vazquez-Perez, Weldon, Halpert, Levitt and Decker.
Conflict of interest statement
Institutional policy requires VK, MH, and WD to declare their ownership stakes in Diakonos Research, Ltd. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures

Similar articles
-
CD161(int)CD8+ T cells: a novel population of highly functional, memory CD8+ T cells enriched within the gut.Mucosal Immunol. 2016 Mar;9(2):401-13. doi: 10.1038/mi.2015.69. Epub 2015 Jul 29. Mucosal Immunol. 2016. PMID: 26220166 Free PMC article.
-
Enhanced Th1/Th17 Functions of CD161+ CD8+ T Cells in Mucosal Tissues of Rhesus Macaques.PLoS One. 2016 Jun 16;11(6):e0157407. doi: 10.1371/journal.pone.0157407. eCollection 2016. PLoS One. 2016. PMID: 27309719 Free PMC article.
-
CD1d-independent developmental acquisition of prompt IL-4 gene inducibility in thymus CD161(NK1)-CD44lowCD4+CD8- T cells is associated with complementarity determining region 3-diverse and biased Vbeta2/Vbeta7/Vbeta8/Valpha3.2 T cell receptor usage.J Immunol. 2005 Nov 15;175(10):6537-50. doi: 10.4049/jimmunol.175.10.6537. J Immunol. 2005. PMID: 16272308
-
Tc17 Cells in Immunity and Systemic Autoimmunity.Int Rev Immunol. 2015;34(4):318-31. doi: 10.3109/08830185.2014.954698. Epub 2014 Sep 26. Int Rev Immunol. 2015. PMID: 25259411 Review.
-
NK-like CD8 T cell: one potential evolutionary continuum between adaptive memory and innate immunity.Clin Exp Immunol. 2024 Jul 12;217(2):136-150. doi: 10.1093/cei/uxae038. Clin Exp Immunol. 2024. PMID: 38651831 Free PMC article. Review.
Cited by
-
Reprogramming and redifferentiation of mucosal-associated invariant T cells reveal tumor inhibitory activity.Elife. 2022 Apr 5;11:e70848. doi: 10.7554/eLife.70848. Elife. 2022. PMID: 35379387 Free PMC article.
-
Induction of tissue resident memory T cells by measles vaccine vector.Hum Vaccin Immunother. 2024 Dec 31;20(1):2436241. doi: 10.1080/21645515.2024.2436241. Epub 2024 Dec 18. Hum Vaccin Immunother. 2024. PMID: 39693193 Free PMC article.
-
Effects of Epstein-Barr Virus Infection on the Risk and Prognosis of Primary Laryngeal Squamous Cell Carcinoma: A Hospital-Based Case-Control Study in Taiwan.Cancers (Basel). 2021 Apr 6;13(7):1741. doi: 10.3390/cancers13071741. Cancers (Basel). 2021. PMID: 33917480 Free PMC article.
-
Dysregulated T-cell homeostasis and decreased CD30+ Treg proliferating in aplastic anemia.Heliyon. 2024 Aug 3;10(15):e35775. doi: 10.1016/j.heliyon.2024.e35775. eCollection 2024 Aug 15. Heliyon. 2024. PMID: 39170389 Free PMC article.
-
HELIOS-expressing human CD8 T cells exhibit limited effector functions.Front Immunol. 2023 Dec 22;14:1308539. doi: 10.3389/fimmu.2023.1308539. eCollection 2023. Front Immunol. 2023. PMID: 38187391 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials